Jeremy S Duffield, MD PhD FRCP

BIIB Vice President and Senior Research Fellow
Affiliate Associate Professor of Medicine & Pathology, University of Washington

Jeremy is a Physician Scientist and Nephrologist. He recently joined Biogen in Cambridge Massachusetts as Vice President and Senior Research Fellow in Discovery Research to help identify next generation therapeutics in fibrogenesis and tissue repair, and to grow the Tissue Injury and Fibrosis Therapeutic Area. He graduated from Oxford and Edinburgh Universities, UK, and practiced Nephrology in Edinburgh. From 2003, he directed the laboratory of inflammation research as Assistant Professor at Harvard Medical School, then as Associate Professor of Medicine & Pathology at the University of Washington in Seattle. His laboratory has been focused on the role of innate immune response cells in injury and repair and on the role of pericytes and fibroblasts in microvascular remodeling and fibrosis. Jeremy is a recipient of the Young Investigator Award from the British Renal Association (2001) and Medical Research Society (2002), NIDDK Young Investigator/Scholar Award (2010), and the American Society of Nephrology Young Investigator Award (2013). In 2011, he became an elected member of the American Society for Clinical Investigation. He also serves on scientific study sections at the NIDDK/NHLBI. He is a cofounder of Muregen, and has served on advisory boards for Promedior Inc. and Regulus Therapeutics; companies dedicated to the development of anti-fibrotic therapies.

In his ‘spare’ time he races bicycles, climbs mountains, skis, plays tennis, grows organic vegetables, looks after children (his own), and fixes things that are broken.